Michael R. Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michael R. Nelson has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Krishnendu Roy
Department of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee, USA; Department of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, Tennessee, USA; Department of Chemical and Biomolecular Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee, USA
3 shared publications - Joscelyn C. Mejias
Translational Tissue Engineering Center, Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD, United States
2 shared publications Albert R. Davalos
The Buck Institute for Research on Aging, Novato, CA 94945, USA
1 shared publicationAnn C. Parplys
Biosciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
1 shared publicationAyesu Hlaing
Biosciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
1 shared publicationBjörn Rydberg
Biosciences, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
1 shared publication
Latest Publications
- 1 March 2021
- Published by Elsevier in Biomaterials
- Vol. 270, 120683
A multi-niche microvascularized human bone marrow (hBM) on-a-chip elucidates key roles of the endosteal niche in hBM physiology
- 1 March 2021
- Published by Elsevier in Biomaterials
- Vol. 270, 120683
A multi-niche microvascularized human bone marrow (hBM) on-a-chip elucidates key roles of the endosteal niche in hBM physiology
- 26 August 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (19) , 3601-3611
A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases
Development of organoids and microfluidic on-chip models has enabled studies of organ-level disease pathophysiologies in vitro. However, current lung-on-a-chip platforms are primarily monolayer epithelial–endothelial co-cultures, separated by a thin membrane, lacking microvasculature-networks or interstitial-fibroblasts. Here we report the design, microfabrication, and characterization of a unique microphysiological on-chip device that recapitulates the human lung interstitium–airway interface through a 3D vascular network, and normal or diseased fibroblasts encapsulated within a fibrin-collagen hydrogel underneath an airlifted airway epithelium. By incorporating fibroblasts from donors with idiopathic pulmonary fibrosis (IPF), or healthy-donor fibroblasts treated with TGF-β1, we successfully created a fibrotic, alpha smooth muscle actin (αSMA)-positive disease phenotype which led to fibrosis-like transformation in club cells and ciliated cells in the airway. Using this device platform, we further modeled the cystic fibrosis (CF) epithelium and recruitment of neutrophils to the vascular networks. Our results suggest that this microphysiological model of the human lung could enable more pathophysiologically relevant studies of complex pulmonary diseases.
- 26 August 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (19) , 3601-3611
A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases
Development of organoids and microfluidic on-chip models has enabled studies of organ-level disease pathophysiologies in vitro. However, current lung-on-a-chip platforms are primarily monolayer epithelial–endothelial co-cultures, separated by a thin membrane, lacking microvasculature-networks or interstitial-fibroblasts. Here we report the design, microfabrication, and characterization of a unique microphysiological on-chip device that recapitulates the human lung interstitium–airway interface through a 3D vascular network, and normal or diseased fibroblasts encapsulated within a fibrin-collagen hydrogel underneath an airlifted airway epithelium. By incorporating fibroblasts from donors with idiopathic pulmonary fibrosis (IPF), or healthy-donor fibroblasts treated with TGF-β1, we successfully created a fibrotic, alpha smooth muscle actin (αSMA)-positive disease phenotype which led to fibrosis-like transformation in club cells and ciliated cells in the airway. Using this device platform, we further modeled the cystic fibrosis (CF) epithelium and recruitment of neutrophils to the vascular networks. Our results suggest that this microphysiological model of the human lung could enable more pathophysiologically relevant studies of complex pulmonary diseases.
- 15 April 2016
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 4 (20) , 3490-3503
Bone-marrow mimicking biomaterial niches for studying hematopoietic stem and progenitor cells
The bone marrow (BM) niche of hematopoietic stem and progenitor cells (HSPCs) is critical for maintaining homeostasis of the hematopoietic system in vivo. It also plays a critical role in many diseases, from cancer metastases to immune dysfunctions. While this microenvironment is well studied, we still do not have a full understanding of bone marrow functions and the HSPC niche. Reconstructing the bone marrow microenvironment in vitro using biomaterials has the potential to further our understanding of the complex HSPC niche, provide new insights on how various cells function within these niches, how complex disease processes happens within the BM, and also serve as a tool for more efficient generation of high quality, therapeutic hematopoietic and mesenchymal cells. Many synthetic and natural materials have been used to replicate the known physical and biochemical properties of bone marrow. Here we review key components and considerations for designing materials to engineer bone marrow niches and study HSPC behavior and disease pathologies. We also provide future perspectives on areas where new knowledge must be gained to achieve the scientific and clinical potential of materials-driven bone marrow niche development.
- 15 April 2016
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 4 (20) , 3490-3503
Bone-marrow mimicking biomaterial niches for studying hematopoietic stem and progenitor cells
The bone marrow (BM) niche of hematopoietic stem and progenitor cells (HSPCs) is critical for maintaining homeostasis of the hematopoietic system in vivo. It also plays a critical role in many diseases, from cancer metastases to immune dysfunctions. While this microenvironment is well studied, we still do not have a full understanding of bone marrow functions and the HSPC niche. Reconstructing the bone marrow microenvironment in vitro using biomaterials has the potential to further our understanding of the complex HSPC niche, provide new insights on how various cells function within these niches, how complex disease processes happens within the BM, and also serve as a tool for more efficient generation of high quality, therapeutic hematopoietic and mesenchymal cells. Many synthetic and natural materials have been used to replicate the known physical and biochemical properties of bone marrow. Here we review key components and considerations for designing materials to engineer bone marrow niches and study HSPC behavior and disease pathologies. We also provide future perspectives on areas where new knowledge must be gained to achieve the scientific and clinical potential of materials-driven bone marrow niche development.
- 1 February 2016
- Published by Elsevier in Molecular Cell
- Vol. 61 (4) , 535-546
Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability
- 1 February 2016
- Published by Elsevier in Molecular Cell
- Vol. 61 (4) , 535-546
Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability
- 10 July 2013
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 81 (11) , 1988-1996
A role for indels in the evolution of Cro protein folds
Insertions and deletions in protein sequences, or indels, can disrupt structure and may result in changes in protein folds during evolution or in association with alternative splicing. Pfl 6 and Xfaso 1 are two proteins in the Cro family that share a common ancestor but have different folds. Sequence alignments of the two proteins show two gaps, one at the N terminus, where the sequence of Xfaso 1 is two residues shorter, and one near the center of the sequence, where the sequence of Pfl 6 is five residues shorter. To test the potential importance of indels in Cro protein evolution, we generated hybrid variants of Pfl 6 and Xfaso 1 with indels in one or both regions, chosen according to several plausible sequence alignments. All but one deletion variant completely unfolded both proteins, showing that a longer N‐terminal sequence was critical for Pfl 6 folding and a longer central region sequence was critical for Xfaso 1 folding. By contrast, Xfaso 1 tolerated a longer N‐terminal sequence with little destabilization, and Pfl 6 tolerated central region insertions, albeit with substantial effects on thermal stability and some perturbation of the surrounding structure. None of the mutations appeared to convert one stable fold into the other. On the basis of this two‐protein comparison, short insertion and deletion mutations probably played a role in evolutionary fold change in the Cro family, but were also not the only factors. Proteins 2013; 81:1988–1996.
- 10 July 2013
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 81 (11) , 1988-1996
A role for indels in the evolution of Cro protein folds
Insertions and deletions in protein sequences, or indels, can disrupt structure and may result in changes in protein folds during evolution or in association with alternative splicing. Pfl 6 and Xfaso 1 are two proteins in the Cro family that share a common ancestor but have different folds. Sequence alignments of the two proteins show two gaps, one at the N terminus, where the sequence of Xfaso 1 is two residues shorter, and one near the center of the sequence, where the sequence of Pfl 6 is five residues shorter. To test the potential importance of indels in Cro protein evolution, we generated hybrid variants of Pfl 6 and Xfaso 1 with indels in one or both regions, chosen according to several plausible sequence alignments. All but one deletion variant completely unfolded both proteins, showing that a longer N‐terminal sequence was critical for Pfl 6 folding and a longer central region sequence was critical for Xfaso 1 folding. By contrast, Xfaso 1 tolerated a longer N‐terminal sequence with little destabilization, and Pfl 6 tolerated central region insertions, albeit with substantial effects on thermal stability and some perturbation of the surrounding structure. None of the mutations appeared to convert one stable fold into the other. On the basis of this two‐protein comparison, short insertion and deletion mutations probably played a role in evolutionary fold change in the Cro family, but were also not the only factors. Proteins 2013; 81:1988–1996.